Pulmonary arterial hypertension

Journal of the American College of Cardiology
Kelly M Chin, L J Rubin

Abstract

Significant advances in the treatment of pulmonary arterial hypertension (PAH) have occurred over the last 10 years, starting with the approval of epoprostenol in 1998. Subsequently, multiple additional medications have received approval, including a subcutaneous prostacyclin, an inhaled prostacyclin, and oral medications in 2 separate classes. Over this same period, the classification of pulmonary hypertension has been revised with changes including the substitution of the term idiopathic for primary PAH and an expanded list of conditions felt to be associated with the development of PAH. Long-term follow-up studies have provided better information on prognosis and expected outcomes with treatment, with particularly valuable data on reassessment of prognosis after treatment with epoprostenol. Combination therapy is more frequently being used, and limited data on novel therapies such as stem cell transplantation have been published. The purpose of this review is to describe the current state of evidence for the diagnosis, prognosis, and treatment of the patient with PAH.

References

Jul 9, 1992·The New England Journal of Medicine·B W ChristmanJ E Loyd
Nov 1, 1991·Chest·R SpeichE W Russi
Jun 17, 1993·The New England Journal of Medicine·A GiaidD J Stewart
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Oct 18, 2000·Chest·N J MehtaD A Sepkowitz
Mar 16, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·R ChannickL J. Rubin
Mar 30, 2002·Journal of the American College of Cardiology·Ronald J RaymondWalker Long
Mar 30, 2002·American Heart Journal·Hideo OyaKunio Miyatake
Sep 5, 2002·Arthritis and Rheumatism·M MaglianoJ Hillson
Sep 18, 2002·Circulation·Vallerie V McLaughlinStuart Rich
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Isabelle O ColleFrançois Durand
Feb 7, 2003·The New England Journal of Medicine·Lingling DuPatricia A Thistlethwaite
Mar 5, 2003·American Journal of Respiratory and Critical Care Medicine·Hilario NunesGérald Simonneau
Mar 26, 2003·Journal of the American College of Cardiology·Xing-Guo SunKarlman Wasserman
Jun 25, 2003·Journal of the American College of Cardiology·Robyn J BarstUNKNOWN Beraprost Study Group
Apr 3, 2004·Circulation Research·Elisabeth MarcosSaadia Eddahibi
Apr 7, 2004·The European Respiratory Journal·S A AbdallaJ H Morse
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-Philippe ZuberUNKNOWN Swiss HIV Cohort Study Group
Jun 15, 2004·Journal of the American College of Cardiology·Gerald SimonneauAlfred Fishman
Jul 14, 2004·Chest·David B BadeschUNKNOWN American College of Chest Physicians
Jul 14, 2004·Chest·Vallerie V McLaughlinUNKNOWN American College of Chest Physicians
Aug 20, 2004·American Journal of Respiratory and Critical Care Medicine·Olivier SitbonGérald Simonneau
Sep 11, 2004·The European Respiratory Journal·M HumbertG Simonneau
Feb 3, 2005·The European Respiratory Journal·V V McLaughlinL J Rubin
Oct 4, 2005·The Journal of Clinical Investigation·Ralph Theo SchermulyFriedrich Grimminger
Nov 3, 2005·The European Respiratory Journal·M M HoeperJ Niedermeyer
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Feb 18, 2006·Pulmonary Pharmacology & Therapeutics·Steven M KawutRobyn J Barst

❮ Previous
Next ❯

Citations

Mar 10, 2012·Pediatric Cardiology·Shinichi TakatsukiDavid Dunbar Ivy
May 28, 2009·European Radiology·Edward T D HoeyNicholas J Screaton
Feb 21, 2009·Current Atherosclerosis Reports·Aydin Uzunpinar, Mehmet Cilingiroglu
Aug 30, 2008·Current Heart Failure Reports·Peter DahlIrwin Klein
Jul 24, 2013·International Journal of Pharmaceutics·Somchai SawatdeeTeerapol Srichana
Oct 19, 2013·Pharmacology & Therapeutics·David MontaniMarc Humbert
Jan 17, 2014·The Lancet. Respiratory Medicine·Paolo SpagnoloVincent Cottin
Apr 25, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ian MorecroftMargaret R Maclean
Sep 9, 2009·Cardiovascular Research·Ian MorecroftMargaret R MacLean
Nov 13, 2009·Current Opinion in Anaesthesiology·Claire GordonWei Pan
Dec 19, 2009·Current Opinion in Anaesthesiology·Alan F Ross, Kenichi Ueda
Sep 5, 2013·Critical Care Nursing Quarterly·Caitlin Kennelly, Diana Esaian
Nov 12, 2009·Journal of Cardiovascular Pharmacology·Ana R L LudkeAdriane Belló-Klein
Sep 15, 2010·Journal of Cardiovascular Pharmacology·Roman GokhmanAmy L Seybert
Mar 12, 2009·Current Opinion in Cardiology·Michael A McDonald, Heather J Ross
Jan 7, 2010·Journal of Hypertension·Patrick Crosswhite, Zhongjie Sun
May 26, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Danielle L BurkeKurt R Stenmark
Feb 28, 2009·American Journal of Respiratory and Critical Care Medicine·Anderson J FerreiraMohan K Raizada
Oct 24, 2009·American Journal of Respiratory and Critical Care Medicine·Bhola Kumar DahalRalph Theo Schermuly
Apr 9, 2009·American Journal of Respiratory and Critical Care Medicine·Marc Humbert
Dec 20, 2012·Therapeutic Advances in Chronic Disease·Shahzad G Raja, Shahbaz M Raja
Jun 28, 2011·Respiratory Research·Djuro KosanovicRalph T Schermuly
May 1, 2013·BMC Pulmonary Medicine·Mirko VölkersF Joachim Meyer
Jan 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongDaniel M Green
May 19, 2010·Vascular Health and Risk Management·Jeremy A FalkErnst R Schwarz
Aug 31, 2011·Applied Health Economics and Health Policy·Noam Y KirsonTodd Williamson
Mar 17, 2010·Future Cardiology·Hossein-Ardeschir GhofraniFriedrich Grimminger
Feb 26, 2011·Journal of Atherosclerosis and Thrombosis·Ahmet CelikIbrahim Ozdogru
Mar 13, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Keiichiro YoshinagaNagara Tamaki
Mar 26, 2010·The International Journal of Cardiovascular Imaging·Gianluca MarroneBruno Gridelli
Feb 9, 2012·Journal of Medical Economics·Qayyim SaidStephen C Mathai
Feb 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Mitchell S BuckleyJeremy P Feldman
Apr 7, 2010·Expert Opinion on Investigational Drugs·Laurence DewachterRobert Naeije
Aug 19, 2009·Current Medical Research and Opinion·Joanna Pepke-ZabaMallik Angalakuditi
Jul 29, 2011·Current Medical Research and Opinion·Noam Y KirsonTodd Williamson
Apr 4, 2012·Clinical and Experimental Hypertension : CHE·Semra Yigitaslan, Basar Sirmagul
Jun 5, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David J RossJohn A Belperio
May 12, 2012·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·José M MatosTony Glaus
Jul 1, 2008·Pharmacology & Therapeutics·Daphne MerkusDirk J Duncker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.